Skip to main content
Top
Published in: Clinical Rheumatology 7/2013

01-07-2013 | Case Based Review

ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review

Authors: Petar Lenert, Michael Icardi, Laila Dahmoush

Published in: Clinical Rheumatology | Issue 7/2013

Login to get access

Abstract

Minocycline is a synthetic tetracycline-derived antibiotic with significant anti-inflammatory properties that may benefit patients with rheumatoid arthritis. Surprisingly, chronic exposure to minocycline can also cause a breach in immunologic tolerance resulting in a variety of autoimmune syndromes such as drug-induced lupus or autoimmune hepatitis. Vasculitis, most commonly resembling cutaneous polyarteritis nodosa, has also been seen in patients taking this drug. Herein, we present a case of biopsy-proven systemic vasculitis presenting as an ANA (+) ANCA (+) polyarteritis nodosa-like syndrome in a male patient who was taking minocycline for his acne for approximately 2 years. Patient initially presented with constitutional symptoms such as profound weight loss and fatigue, along with myalgias, oligoarticular arthritis, and livedo reticularis. About 2 months later, he developed a severe left testicular pain. Biopsy showed vasculitis complicated with the infarction of the left testis. Angiography revealed microaneurysms in the renal and splenic circulation. Stopping the offending drug, along with the short course of prednisone and hydroxychloroquine, resulted in prompt resolution of his symptoms. We additionally present a comprehensive review of biopsy-proven cases of vasculitis associated with chronic minocycline treatment focusing on its pathogenesis and clinical manifestations.
Literature
2.
go back to reference Sturkenboom MC, Meier CR, Jick H, Stricker BH (1999) Minocycline and lupus-like syndrome in acne patients. Arch Intern Med 159:493–497PubMedCrossRef Sturkenboom MC, Meier CR, Jick H, Stricker BH (1999) Minocycline and lupus-like syndrome in acne patients. Arch Intern Med 159:493–497PubMedCrossRef
3.
go back to reference Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S (1992) Minocycline-related lupus. Lancet 340:1553PubMedCrossRef Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S (1992) Minocycline-related lupus. Lancet 340:1553PubMedCrossRef
4.
5.
go back to reference Masson C, Chevailler A, Pascaretti C, Legrand E, Brégeon C, Audran M (1996) Minocycline-related lupus. J Rheumatol 23:2160–2161PubMed Masson C, Chevailler A, Pascaretti C, Legrand E, Brégeon C, Audran M (1996) Minocycline-related lupus. J Rheumatol 23:2160–2161PubMed
6.
go back to reference Quilty B, McHugh N (1994) Lupus-like syndrome associated with the use of minocycline. Br J Rheumatol 33:1197–1198PubMedCrossRef Quilty B, McHugh N (1994) Lupus-like syndrome associated with the use of minocycline. Br J Rheumatol 33:1197–1198PubMedCrossRef
8.
go back to reference Gordon PM, White MI, Herriot R, Martin JC, Reid DM (1995) Minocycline-associated lupus erythematosus. Br J Dermatol 132:120–121PubMedCrossRef Gordon PM, White MI, Herriot R, Martin JC, Reid DM (1995) Minocycline-associated lupus erythematosus. Br J Dermatol 132:120–121PubMedCrossRef
9.
go back to reference Inoue CN, Kondo Y, Suwabe N, Igarashi Y, Tada K (1994) Minocycline-related lupus in childhood. Eur J Pediatr 153:540PubMedCrossRef Inoue CN, Kondo Y, Suwabe N, Igarashi Y, Tada K (1994) Minocycline-related lupus in childhood. Eur J Pediatr 153:540PubMedCrossRef
10.
go back to reference Gendi NS, Bowman SJ, Mowat AG (1995) Lupus-like syndrome in patients treated for acne. Br J Rheumatol 34:584–585PubMedCrossRef Gendi NS, Bowman SJ, Mowat AG (1995) Lupus-like syndrome in patients treated for acne. Br J Rheumatol 34:584–585PubMedCrossRef
11.
go back to reference Elkayam O, Yaron M, Caspi D (1996) Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 55:769–771PubMedCrossRef Elkayam O, Yaron M, Caspi D (1996) Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 55:769–771PubMedCrossRef
12.
go back to reference Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 142:461–467PubMedCrossRef Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 142:461–467PubMedCrossRef
13.
go back to reference Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D (1998) Clinical and immunological study of seven patients with minocycline-induced autoimmune phenomena. Am J Med 105:484–487PubMedCrossRef Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D (1998) Clinical and immunological study of seven patients with minocycline-induced autoimmune phenomena. Am J Med 105:484–487PubMedCrossRef
14.
go back to reference Elkayam O, Yaron M, Caspi D (1999) Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 28:392–397PubMedCrossRef Elkayam O, Yaron M, Caspi D (1999) Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 28:392–397PubMedCrossRef
15.
go back to reference El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, Dedeoglu F (2008) Chronic minocycline-induced autoimmunity in children. J Pediatr 153:314–319PubMedCrossRef El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, Dedeoglu F (2008) Chronic minocycline-induced autoimmunity in children. J Pediatr 153:314–319PubMedCrossRef
16.
go back to reference Schaffer JV, Davidson DM, McNiff JM, Bolognia JL (2001) Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 44:198–206PubMedCrossRef Schaffer JV, Davidson DM, McNiff JM, Bolognia JL (2001) Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 44:198–206PubMedCrossRef
17.
go back to reference Lawson TM, Amos N, Bulgen D, Williams BD (2001) Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40:329–335CrossRef Lawson TM, Amos N, Bulgen D, Williams BD (2001) Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology (Oxford) 40:329–335CrossRef
19.
go back to reference Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol 51:190–192CrossRef Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol 51:190–192CrossRef
20.
go back to reference Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J 289:410–412CrossRef Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J 289:410–412CrossRef
21.
go back to reference Yokogawa N, Vivino FB (2009) Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol 19:338–347PubMedCrossRef Yokogawa N, Vivino FB (2009) Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol 19:338–347PubMedCrossRef
22.
go back to reference Marina VP, Malhotra D, Kaw D (2012) Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. Int Urol Nephrol 44(6):1907–9PubMedCrossRef Marina VP, Malhotra D, Kaw D (2012) Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. Int Urol Nephrol 44(6):1907–9PubMedCrossRef
25.
go back to reference Shapiro LE, Uetrecht J, Shear NH (2001) Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol 45:787–789PubMedCrossRef Shapiro LE, Uetrecht J, Shear NH (2001) Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: the biochemical basis. J Am Acad Dermatol 45:787–789PubMedCrossRef
26.
go back to reference Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20PubMedCrossRef Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20PubMedCrossRef
27.
go back to reference Gaffney K, Merry P (1996) Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. Br J Rheumatol 35:1327PubMedCrossRef Gaffney K, Merry P (1996) Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. Br J Rheumatol 35:1327PubMedCrossRef
28.
go back to reference Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, Gough A, Cunliffe WJ, Emery P (2007) Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol 156:1005–1009PubMedCrossRef Marzo-Ortega H, Baxter K, Strauss RM, Drysdale S, Griffiths B, Misbah SA, Gough A, Cunliffe WJ, Emery P (2007) Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol 156:1005–1009PubMedCrossRef
29.
go back to reference Schrodt BJ, Callen JP (1999) Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 103:503–504PubMedCrossRef Schrodt BJ, Callen JP (1999) Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 103:503–504PubMedCrossRef
30.
go back to reference Schrodt BJ, Kulp-Shorten CL, Callen JP (1999) Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 92:502–504PubMedCrossRef Schrodt BJ, Kulp-Shorten CL, Callen JP (1999) Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 92:502–504PubMedCrossRef
31.
go back to reference Sakai H, Komatsu S, Matsuo S, Iizuka H (2002) Two cases of minocycline-induced vasculitis. Arerugi 51:1153–1158PubMed Sakai H, Komatsu S, Matsuo S, Iizuka H (2002) Two cases of minocycline-induced vasculitis. Arerugi 51:1153–1158PubMed
32.
go back to reference Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F (2003) Minocycline- induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 13:396–398PubMed Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F (2003) Minocycline- induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 13:396–398PubMed
33.
go back to reference Culver B, Itkin A, Pischel K (2005) Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 53:468–470PubMedCrossRef Culver B, Itkin A, Pischel K (2005) Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 53:468–470PubMedCrossRef
34.
go back to reference Tehrani R, Nash-Goelitz A, Adams E, Dahiya M, Eilers D (2007) Minocycline- induced cutaneous polyarteritis nodosa. J Clin Rheumatol 13:146–149PubMedCrossRef Tehrani R, Nash-Goelitz A, Adams E, Dahiya M, Eilers D (2007) Minocycline- induced cutaneous polyarteritis nodosa. J Clin Rheumatol 13:146–149PubMedCrossRef
35.
go back to reference Katada Y, Harada Y, Azuma N, Matsumoto K et al (2006) Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol 16:256–259PubMedCrossRef Katada Y, Harada Y, Azuma N, Matsumoto K et al (2006) Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol 16:256–259PubMedCrossRef
36.
go back to reference Ogawa N, Kawai H, Yamakawa I, Sanada M, Sugimoto T, Maeda K (2010) Case of minocycline-induced vasculitic neuropathy. Rinsho Shinkeigaku 50:301–305PubMedCrossRef Ogawa N, Kawai H, Yamakawa I, Sanada M, Sugimoto T, Maeda K (2010) Case of minocycline-induced vasculitic neuropathy. Rinsho Shinkeigaku 50:301–305PubMedCrossRef
37.
go back to reference Towns K, Szmitko PE, Smith C, Detsky AS, Mourad O (2011) Clinical problem solving. It's not all in your head. N Engl J Med 365:1329–1334PubMedCrossRef Towns K, Szmitko PE, Smith C, Detsky AS, Mourad O (2011) Clinical problem solving. It's not all in your head. N Engl J Med 365:1329–1334PubMedCrossRef
38.
go back to reference Abad S, Kambouchner M, Nejjari M, Dhote R (2006) Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al. Arthritis Rheum 55:831PubMedCrossRef Abad S, Kambouchner M, Nejjari M, Dhote R (2006) Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al. Arthritis Rheum 55:831PubMedCrossRef
39.
go back to reference Gait RC, Affleck AG, Leach IH, Varma S (2008) Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol 58(Suppl 1):S123–S124PubMedCrossRef Gait RC, Affleck AG, Leach IH, Varma S (2008) Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol 58(Suppl 1):S123–S124PubMedCrossRef
40.
go back to reference Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64:625–639CrossRef Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64:625–639CrossRef
41.
go back to reference BNF 51 (2006) British National Formulary, vol 5.1.3. BMJ Publishing, London, pp 285–287 BNF 51 (2006) British National Formulary, vol 5.1.3. BMJ Publishing, London, pp 285–287
Metadata
Title
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review
Authors
Petar Lenert
Michael Icardi
Laila Dahmoush
Publication date
01-07-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2245-z

Other articles of this Issue 7/2013

Clinical Rheumatology 7/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.